Crinetics Pharmaceuticals Inc

NASDAQ:CRNX   3:59:52 PM EDT
19.65
-0.49 (-2.43%)
Earnings Announcements

Crinetics Pharmaceuticals Reports Q1 2022 Results

Published: 05/12/2022 20:48 GMT
Crinetics Pharmaceuticals Inc (CRNX) - Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Crinetics Pharmaceuticals Inc- Qtrly Loss per Share $0.73.
Revenue is expected to be $0.43 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0.65 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.